Dr.Daniel Acosta's second opinion

Dr. Daniel Acosta



15 years of experience

Choose for Consultation

Area of expertise




Medical Oncology


Pancreatic Cancer, Gastric Cancer, Biliary Tract Cancer, Liver Cancer, Esophageal Cancer, Colorectal Cancer, Neuroendocrine Tumors, Gastrointestinal Cancers

Procedures Performed



Targeted Therapy


Medical Oncologist, Vall d’Hebron University Hospital

Barcelona, Spain. From 2019

Medical Oncologist, GenesisCare

Madrid, Spain. 2016 - 2019

Medical Oncologist, Comprehensive Cancer Center CLARA CAMPAL

Madrid, Spain. 2014 - 2016

Medical Oncology Residency Program, San Carlos Clinical Hospital

Madrid, Spain. 2009 - 2014


MD, University of San Martin de Porres



Dr. Acosta is a medical oncologist with extensive experience in treating digestive tumors, including pancreas, biliary tract, liver, esophageal, gastric, colon, and neuroendocrine tumors. He completed his Medical Oncology Residency Program at San Carlos Clinical Hospital in Madrid, Spain, in 2014 and holds an MD from the University of San Martin de Porres. Dr. Acosta has worked at several medical institutions in Spain, including GenesisCare in Madrid from 2016 to 2019, and the Comprehensive C


Spanish Society of Medical Oncology

European Society for Medical Oncology

American Society of Clinical Oncology

The European Neuroendocrine Tumor Society

Spanish Group of Neuroendocrine and Endocrine Tumors


Experience with eribulin in patients with metastatic breast cancer and associated hepatic impairment: Case studies

Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital PCR. cfDNA a powerful tool for biomarker testing in advance disease

Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging

You’re only one click away from a life-changing journey

Virtual health assistant powered by AI
350+ world-renowned Doctors